# US 2014/0190498 A1 · Nicotiana nucleic acid molecules and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0190498 A1
- Document ID: US20140190498A1
- Status: Published application
- Kind: A1
- Application number: 14/184,914
- Filed: 2014-02-20
- Published: 2014-07-10
- Earliest claimed: 2004-04-29
- Assignees: U.S. Smokeless Tobacco Company LLC
- Applicants: U.S. Smokeless Tobacco Company
- Inventors: Dongmei Xu; Mark T. Nielsen
- Web page: https://patentgrep.com/patent/US20140190498A1

## CPC

- A24B 15/10: Chemical features of tobacco products or tobacco substitutes
- A24B 15/20: Biochemical treatment
- C07K 14/415: from plants
- C12N 9/0077: {with a reduced iron-sulfur protein as one donor (1.14.15)}
- C12N 15/8261: {with agronomic (input) traits, e.g. crop yield}
- C12Q 1/6844: Nucleic acid amplification reactions
- C12Q 2560/00: Nucleic acid detection
- C12Q 2600/13: Plant traits
- A24B: MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present invention features Nicotiana nucleic acid sequences such as sequences encoding constitutive, or ethylene or senescence induced polypeptides, in particular cytochrome p450 enzymes, in Nicotiana plants and methods for using these nucleic acid sequences and plants to alter desirable traits, for example by using breeding protocols.

## Claims

### Claim 1

(canceled)

### Claim 2

A method of producing a tobacco product comprising:
a) providing cured plant material from a Nicotiana tabacum plant having a mutation in an endogenous nucleic acid, the wild type endogenous nucleic acid having the nucleotide sequence set forth in SEQ ID NO: 192; and
b) manufacturing a tobacco product using said cured plant material.

### Claim 3 (depends on 2)

The method of claim 2, wherein said cured plant material is cured leaf.

### Claim 4 (depends on 3)

The method of claim 3, wherein said tobacco product is a smokeless tobacco product.

### Claim 5 (depends on 3)

The method of claim 3, wherein said tobacco product is a cigarette.

### Claim 6 (depends on 3)

The method of claim 3, wherein said tobacco product is a cigar.

### Claim 7 (depends on 3)

The method of claim 3, wherein said mutation is selected from the group consisting of a point mutation, a deletion, an insertion, a duplication and an inversion.

### Claim 8 (depends on 7)

The method of claim 7, wherein said mutation is a point mutation.

### Claim 9 (depends on 7)

The method of claim 7, wherein said mutation is a deletion.

### Claim 10

A tobacco product comprising cured plant material from a Nicotiana tabacum plant having a mutation in an endogenous nucleic acid, the wile type endogenous nucleic acid having the nucleotide sequence set forth in SEQ ID NO: 192.

### Claim 11 (depends on 10)

The tobacco product of claim 10, wherein said plant material is cured leaf.

### Claim 12 (depends on 10)

The tobacco product of claim 10, wherein said mutation is selected from the group consisting of a point mutation, a deletion, an insertion, a duplication and an inversion.

### Claim 13 (depends on 12)

The tobacco product of claim 12, wherein said mutation is a point mutation.

### Claim 14 (depends on 12)

The tobacco product of claim 12, wherein said mutation is a deletion.

### Claim 15 (depends on 10)

The tobacco product of claim 10, wherein said tobacco product is a chewing tobacco.

### Claim 16 (depends on 10)

The tobacco product of claim 10, wherein said tobacco product is a moist or dry snuff.

### Claim 17 (depends on 10)

The tobacco product of claim 10, wherein said tobacco product is a cigarette.

### Claim 18 (depends on 10)

The tobacco product of claim 10, wherein said tobacco product is a cigarillo.

### Claim 19 (depends on 10)

The tobacco product of claim 10, wherein said tobacco product is a cigar.

### Claim 20 (depends on 11)

The tobacco product of claim 11, wherein said mutation is a point mutation or deletion.

### Claim 21 (depends on 20)

The tobacco product of claim 20, wherein said tobacco product is selected from the group consisting of a chewing tobacco, a moist or dry snuff and a cigarette.
